Search Results

Peptide-Based Prodrug Approaches for Cancer Nanomedicine.

• Authors : Khaliq NU; Department of Chemistry and Bioscience, Kumoh National Institute of Technology, 61 Daehak-ro, Gumi 39177, Gyeongbuk Korea.; Amin L

Subjects: Prodrugs*/Prodrugs*/Prodrugs*/chemistry ; Prodrugs*/Prodrugs*/Prodrugs*/pharmacology ; Peptides*/Peptides*/Peptides*/chemistry

• Source: ACS applied bio materials [ACS Appl Bio Mater] 2024 Dec 16; Vol. 7 (12), pp. 8163-8176. Date of Electronic Publication: 2024 Nov 27.Publisher: ACS Publications Country of Publication: United States NLM ID: 101729147 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Orally Delivered Stimulus-Sensitive Nanomedicine to Harness Teduglutide Efficacy in Inflammatory Bowel Disease.

• Authors : Barros AS; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, 4200-135, Portugal.; ICBAS- Instituto Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, 4050-313, Portugal.

Subjects: Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/drug therapy ; Peptides*/Peptides*/Peptides*/chemistry ; Peptides*/Peptides*/Peptides*/pharmacology

• Source: Small (Weinheim an der Bergstrasse, Germany) [Small] 2024 Nov; Vol. 20 (45), pp. e2402502. Date of Electronic Publication: 2024 Jul 15.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101235338 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-6829

Record details

Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma.

• Authors : Wang L; Department of Clinical Research Center, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, 310006, P. R. China.; Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, P. R. China.

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Sep 03; Vol. 22 (1), pp. 533. Date of Electronic Publication: 2024 Sep 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition.

• Authors : Sun F; School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016, China.; Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.

Subjects: Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/drug effects ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/metabolism ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/pathology

• Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Jul 31; Vol. 16 (30), pp. 38968-38978. Date of Electronic Publication: 2024 Jul 18.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Chimeric Peptide-Engineered Self-Delivery Nanomedicine for Photodynamic-Triggered Breast Cancer Immunotherapy by Macrophage Polarization.

• Authors : Liu YB; Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, P. R.China.; Chen XY

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

• Source: Small (Weinheim an der Bergstrasse, Germany) [Small] 2024 May; Vol. 20 (22), pp. e2309994. Date of Electronic Publication: 2023 Dec 14.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101235338 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-6829

Record details

Agricola

Record details

Hyaluronic acid-shelled, peptide drug conjugate-cored nanomedicine for the treatment of hepatocellular carcinoma.

• Authors : Wang J; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.; Qian Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy ; Nanomedicine*

• Source: Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2020 Dec; Vol. 117, pp. 111261. Date of Electronic Publication: 2020 JulPublisher: Elsevier Country of Publication: Netherlands NLM ID: 101484109 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance.

• Authors : Luo YL; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.; Liang LF

Subjects: Nanomedicine*; Autoantigens/Autoantigens/Autoantigens/*immunology ; CRISPR-Cas Systems/CRISPR-Cas Systems/CRISPR-Cas Systems/*immunology

• Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2020 Oct 28; Vol. 12 (43), pp. 48259-48271. Date of Electronic Publication: 2020 Oct 19.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Agricola

Record details

Biomedical Applications of a Novel Class of High-Affinity Peptides.

• Authors : Saw PE; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou 510120, P.R. China.; Biomedical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou 510120, P.R. China.

Subjects: Nanomedicine*; Peptides/Peptides/Peptides/*metabolism; Animals

• Source: Accounts of chemical research [Acc Chem Res] 2021 Sep 21; Vol. 54 (18), pp. 3576-3592. Date of Electronic Publication: 2021 Aug 18.Publisher: American Chemical Society Country of Publication: United States NLM ID: 0157313 Publication Model: Print-Electronic Cited Medium: Internet

Record details